Company Lonza Group Ltd Other OTC
Equities
LZAGY
US54338V1017
Biotechnology & Medical Research
Business Summary
- bio-pharmaceuticals (52.6%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.;
- capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (20.3%). In addition, the group offers nutritional ingredients;
- small molecule drug substances (13.2%);
- technologies and platforms for manufacturing processes and production of cell and gene therapies (11.1%);
- other (2.8%).
Net sales are distributed geographically as follows: Switzerland (16%), Europe (29.8%), the United States (38.8%), the Americas (3%), Japan (3.7%), China (2.6%), Asia (5.8%) and other (0.3%).
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics
55.4
%
| 3,274 | 52.6 % | 3,719 | 55.4 % | +13.59% |
Capsules & Health Ingredients
17.3
%
| 1,266 | 20.3 % | 1,161 | 17.3 % | -8.29% |
Small Molecules
13.4
%
| 819 | 13.2 % | 901 | 13.4 % | +10.01% |
Cell & Gene
10.4
%
| 693 | 11.1 % | 696 | 10.4 % | +0.43% |
Corporate/Eliminations
3.6
%
| 171 | 2.7 % | 240 | 3.6 % | +40.35% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
31.8
%
| 2,415 | 38.8 % | 2,136 | 31.8 % | -11.55% |
Switzerland
17.4
%
| 996 | 16.0 % | 1,168 | 17.4 % | +17.27% |
Japan
8.1
%
| 227 | 3.6 % | 544 | 8.1 % | +139.65% |
Ireland
5.5
%
| 343 | 5.5 % | 368 | 5.5 % | +7.29% |
Belgium
5.1
%
| 302 | 4.9 % | 341 | 5.1 % | +12.91% |
Denmark
4.8
%
| 158 | 2.5 % | 322 | 4.8 % | +103.80% |
Germany
4.5
%
| 224 | 3.6 % | 302 | 4.5 % | +34.82% |
Rest of Europe
2.9
%
| 207 | 3.3 % | 195 | 2.9 % | -5.80% |
China
2.6
%
| 161 | 2.6 % | 172 | 2.6 % | +6.83% |
United Kingdom
2.5
%
| 139 | 2.2 % | 171 | 2.5 % | +23.02% |
Singapore
2.0
%
| 113 | 1.8 % | 137 | 2.0 % | +21.24% |
Sweden
1.8
%
| 143 | 2.3 % | 123 | 1.8 % | -13.99% |
France
1.7
%
| 116 | 1.9 % | 111 | 1.7 % | -4.31% |
South Korea
1.4
%
| 141 | 2.3 % | 97 | 1.4 % | -31.21% |
Canada
1.3
%
| 63 | 1.0 % | 90 | 1.3 % | +42.86% |
Netherlands
1.3
%
| 132 | 2.1 % | 88 | 1.3 % | -33.33% |
Brazil
1.1
%
| 49 | 0.8 % | 71 | 1.1 % | +44.90% |
Italy
0.8
%
| 41 | 0.7 % | 52 | 0.8 % | +26.83% |
India
0.6
%
| 42 | 0.7 % | 42 | 0.6 % | -.--% |
Spain
0.6
%
| 41 | 0.7 % | 40 | 0.6 % | -2.44% |
Mexico
0.5
%
| 34 | 0.5 % | 33 | 0.5 % | -2.94% |
Rest of Asia
0.4
%
| 36 | 0.6 % | 29 | 0.4 % | -19.44% |
Rest of Latin America
0.4
%
| 38 | 0.6 % | 26 | 0.4 % | -31.58% |
Australia & New Zealand
0.2
%
| 21 | 0.3 % | 16 | 0.2 % | -23.81% |
Thailand
0.2
%
| 15 | 0.2 % | 15 | 0.2 % | -.--% |
Indonesia
0.2
%
| 16 | 0.3 % | 14 | 0.2 % | -12.50% |
Czech Republic
0.2
%
| 7 | 0.1 % | 11 | 0.2 % | +57.14% |
Other Countries
0.0
%
| 2 | 0.0 % | 2 | 0.0 % | -.--% |
Rest of North and Central America
0.0
%
| 1 | 0.0 % | 1 | 0.0 % | -.--% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/17/25 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01/21/01 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01/22/01 |
Lyle Wheeler
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16/14/16 |
Director/Board Member | 66 | 16/14/16 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05/22/05 |
Albert Baehny
CEO | Chief Executive Officer | 72 | 25/17/25 |
Christoph Mäder
BRD | Director/Board Member | 64 | 26/16/26 |
Roger Nitsch
BRD | Director/Board Member | 63 | 01/22/01 |
Director/Board Member | 64 | 04/18/04 | |
Director/Board Member | 52 | 04/18/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,468,752 | 71,395,423 ( 95.87 %) | 2,352,163 ( 3.159 %) | 95.87 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LONZA GROUP AG 3.16% | 2,352,163 | 3.16% | 1,308,994,140 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Arch Protection Chemicals Pvt Ltd.
Arch Protection Chemicals Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Lonza Group AG, Arch Protection Chemicals Pvt Ltd. is an Indian company that provides business services. The private company is based in Mumbai, India. |
Miscellaneous Commercial Services
|
Arch UK Biocides Ltd.
Arch UK Biocides Ltd. Household/Personal CareConsumer Non-Durables Part of Lonza Group AG, Arch UK Biocides Ltd. is a provider of integrated healthcare solutions to the pharmaceutical, biotech, and specialty ingredients markets. The private company is based in Castleford, UK, and offers careers in various disciplines such as bioengineering and chemistry. Lonza optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers. Lonza's quality management is committed to meeting all specifications and fulfilling customer needs and expectations. Founded in 2003, the British company's solutions aim to improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment. |
Household/Personal Care
|
Capsugel Italy SRL
Capsugel Italy SRL Miscellaneous Commercial ServicesCommercial Services Part of Chester Investor Holdings SRL, Capsugel Italy SRL provides management consulting services. The private company is based in Milan, Italy. |
Miscellaneous Commercial Services
|
Capsugel SA
Capsugel SA Pharmaceuticals: MajorHealth Technology Capsugel SA engages in the manufacture and sell of capsules for pharmaceutical, consumer healthcare and, dietary supplement industries. The company was founded on November 13, 2013 and is headquartered in Luxembourg. |
Pharmaceuticals: Major
|
Hickson Ltd.
Hickson Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1937, Hickson Ltd. is a business consulting British company that provides consulting services. The private company is based in Castleford, UK and is part of Lonza Group AG. |
Miscellaneous Commercial Services
|
Capsugel Hungary Kft
| |
Innovative Water Care Europe SAS
Innovative Water Care Europe SAS Specialty StoresRetail Trade Innovative Water Care Europe SAS manufactures basic organic chemicals. The company was founded on September 17, 1982 and is headquartered in Amboise, France. |
Specialty Stores
|
Capsugel France SAS
Capsugel France SAS Apparel/Footwear RetailRetail Trade Capsugel France SAS manufactures & distributes clothes and clothing accessories. The company was founded in 1970 and is headquartered in Colmar, France. |
Apparel/Footwear Retail
|
Capsugel Financeco SCA
Capsugel Financeco SCA Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel Financeco SCA is a Luxembourger pharmaceutical company founded in 2011. The private company manufactures pharmaceutical products and is based in Luxembourg, Luxembourg. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+29.03% | 4.82TCr | |
-0.10% | 4.17TCr | |
-5.26% | 2.88TCr | |
+11.48% | 2.56TCr | |
-22.74% | 1.9TCr | |
+9.06% | 1.29TCr | |
+30.01% | 1.2TCr | |
-1.51% | 1.18TCr | |
+22.69% | 1.17TCr |